Page 5,222«..1020..5,2215,2225,2235,224..5,2305,240..»

Technique Could Identify Patients at High Risk of Stroke or Brain Hemorrhage

Posted: Published on May 31st, 2013

Newswise Measuring blood flow in the brain may be an easy, noninvasive way to predict stroke or hemorrhage in children receiving cardiac or respiratory support through a machine called ECMO, according to a new study by researchers at Nationwide Childrens Hospital. Early detection would allow physicians to alter treatment and take steps to prevent these complicationsthe leading cause of death for patients on ECMO. Short for extracorporeal membrane oxygenation, ECMO is used when a patient is unable to sustain enough oxygen in the blood supply due to heart failure, septic shock, or other life-threatening condition, said Nicole OBrien, MD, a physician and scientist in critical care medicine at Nationwide Childrens and lead author of the study, which appears in a recent issue of the journal Pediatric Critical Care Medicine. The patient is connected to ECMO with tubes that carry the patients blood from a vein through the machine, where it is oxygenated and funneled back to the patient via an artery or vein that then distributes the oxygen-rich blood to vital organs and tissues. The disease processes that lead someone to need ECMO are different, OBrien noted, but it is used only after traditional therapies, such as a ventilator, fail. … Continue reading

Posted in Brain Injury Treatment | Comments Off on Technique Could Identify Patients at High Risk of Stroke or Brain Hemorrhage

From trauma to tau: Researchers tie brain injury to toxic form of protein

Posted: Published on May 31st, 2013

May 29, 2013 University of Texas Medical Branch at Galveston researchers have uncovered what may be a key molecular mechanism behind the lasting damage done by traumatic brain injury. The discovery centers on a particular form of a protein that neuroscientists call tau, which has also been associated with Alzheimer's disease and other neurodegenerative conditions. Under ordinary conditions, tau is essential to neuron health, but in Alzheimer's the protein aggregates into two abnormal forms: so-called "neurofibrillary tangles," and collections of two, three, or four or more tau units known as "oligomers." Neurofibrillary tangles are not believed to be harmful, but tau oligomers are toxic to nerve cells. They also are thought to have an additional damaging property -- when they come into contact with healthy tau proteins, they cause them to also clump together into oligomers, and so spread toxic tau oligomers to other parts of the brain. Now, in experiments with laboratory rats, using novel antibodies developed at UTMB, scientists have found that traumatic brain injuries also generate tau oligomers. The destructive protein assemblages formed within four hours after injury and persisted for at least two weeks -- long enough to suggest that they might contribute to lasting brain … Continue reading

Posted in Brain Injury Treatment | Comments Off on From trauma to tau: Researchers tie brain injury to toxic form of protein

Marijuana May Help Protect, Heal The Brain

Posted: Published on May 31st, 2013

May 30, 2013 Michael Harper for redOrbit.com Your Universe Online A new study from Tel Aviv University has found that THC, the psychoactive component in marijuana, can protect the brain from cognitive damage, especially following injury. Medical marijuana has been found to be beneficial in treating pain, insomnia and lack of appetite, but this study has found that THC also helps the brain protect itself before and after an injury. Professor Yosef Sarne at Tel Aviv Universitys Adelson Center for the Biology of Addictive Diseases at the Sackler Faculty of Medicine discovered this as he was performing experiments to discover the biological makeup of marijuana and tested his hypothesis on lab mice. His results are published in the journals Behavioural Brain Research and Experimental Brain Research. According to Professor Sarne, only a very small dose of THC is needed to protect the brain from long term cognitive damage brought on by injury, seizures, or even damage from toxic drugs. Without this barrier of protection, brains are susceptible to cognitive defects and neurological damage. This isnt the first time THC has been found to protect brain cells. Previous research observed that, when administered 30 minutes before or after a brain injury, … Continue reading

Posted in Brain Injury Treatment | Comments Off on Marijuana May Help Protect, Heal The Brain

Low doses of THC (cannabis) can halt brain damage, study suggests

Posted: Published on May 31st, 2013

May 30, 2013 hough marijuana is a well-known recreational drug, extensive scientific research has been conducted on the therapeutic properties of marijuana in the last decade. Medical cannabis is often used by sufferers of chronic ailments, including cancer and post-traumatic stress disorder, to combat pain, insomnia, lack of appetite, and other symptoms. Now Prof. Yosef Sarne of Tel Aviv University's Adelson Center for the Biology of Addictive Diseases at the Sackler Faculty of Medicine says that the drug has neuroprotective qualities as well. He has found that extremely low doses of THC -- the psychoactive component of marijuana -- protects the brain from long-term cognitive damage in the wake of injury from hypoxia (lack of oxygen), seizures, or toxic drugs. Brain damage can have consequences ranging from mild cognitive deficits to severe neurological damage. Previous studies focused on injecting high doses of THC within a very short time frame -- approximately 30 minutes -- before or after injury. Prof. Sarne's current research, published in the journals Behavioural Brain Research and Experimental Brain Research, demonstrates that even extremely low doses of THC -- around 1,000 to 10,000 times less than that in a conventional marijuana cigarette -- administered over a wide … Continue reading

Posted in Brain Injury Treatment | Comments Off on Low doses of THC (cannabis) can halt brain damage, study suggests

Low doses of THC can halt brain damage

Posted: Published on May 31st, 2013

Public release date: 30-May-2013 [ | E-mail | Share ] Contact: George Hunka ghunka@aftau.org 212-742-9070 American Friends of Tel Aviv University Though marijuana is a well-known recreational drug, extensive scientific research has been conducted on the therapeutic properties of marijuana in the last decade. Medical cannabis is often used by sufferers of chronic ailments, including cancer and post-traumatic stress disorder, to combat pain, insomnia, lack of appetite, and other symptoms. Now Prof. Yosef Sarne of Tel Aviv University's Adelson Center for the Biology of Addictive Diseases at the Sackler Faculty of Medicine says that the drug has neuroprotective qualities as well. He has found that extremely low doses of THC the psychoactive component of marijuana protects the brain from long-term cognitive damage in the wake of injury from hypoxia (lack of oxygen), seizures, or toxic drugs. Brain damage can have consequences ranging from mild cognitive deficits to severe neurological damage. Previous studies focused on injecting high doses of THC within a very short time frame approximately 30 minutes before or after injury. Prof. Sarne's current research, published in the journals Behavioural Brain Research and Experimental Brain Research, demonstrates that even extremely low doses of THC around 1,000 to 10,000 times … Continue reading

Posted in Brain Injury Treatment | Comments Off on Low doses of THC can halt brain damage

Relapsing MS patients more satisfied with Novartis oral drug Gilenya® than standard injectable therapies, according to …

Posted: Published on May 31st, 2013

EAST HANOVER, N.J., May 30, 2013 /PRNewswire/ --People with relapsing multiple sclerosis (MS) reported greater treatment satisfaction after starting the oral treatment Gilenya (fingolimod) vs. switching to, or staying on, injectable interferon beta or glatiramer acetate, according to new study data presented at the 2013 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) in Orlando, Fla.1 The US phase IV randomized, multi-center, open-label study, called EPOC (Evaluate Patient OutComes), evaluated treatment satisfaction among more than 1,000 patients.1,2 The study compared Gilenya to interferon beta or glatiramer acetate using a 100-point scale based on the Treatment Satisfaction Questionnaire for Medication (TSQM),1 a validated tool that measures patient satisfaction with medical treatments.3 A higher TSQM score indicates higher satisfaction. At six months, adjusted mean treatment global satisfaction subscale scores (a measure of the overall level of satisfaction with a medication that patients are taking) were 80.4 for Gilenya vs. 61.1 for the injectable disease modifying therapies (DMTs), an increase from baseline by 20.4 vs. 2.9, respectively.1 The mean difference between the two scores was a statistically significant 17.5 (p1 "Patient satisfaction is critical for the management of chronic conditions like MS," said Christopher LaGanke, MD, of North Central Neurology Associates … Continue reading

Posted in MS Treatment | Comments Off on Relapsing MS patients more satisfied with Novartis oral drug Gilenya® than standard injectable therapies, according to …

JAY CUTLER DIET WHAT HE EATS FOR TRAINING! – Video

Posted: Published on May 31st, 2013

JAY CUTLER DIET WHAT HE EATS FOR TRAINING! By: enterbackspacetab400 … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on JAY CUTLER DIET WHAT HE EATS FOR TRAINING! – Video

I can’t stop BODYBUILDING – Video

Posted: Published on May 31st, 2013

I can't stop BODYBUILDING By: enterbackspacetab100 … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on I can’t stop BODYBUILDING – Video

Duke Stem Cell Research – Video

Posted: Published on May 31st, 2013

Duke Stem Cell Research By: Duke Cell Biology … Continue reading

Posted in Stem Cell Research | Comments Off on Duke Stem Cell Research – Video

International Stem Cell Corporation Initiates IND-Enabling Study in Parkinson's Disease Program

Posted: Published on May 31st, 2013

CARLSBAD, CA--(Marketwired - May 30, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company developing novel stem cell based therapies, announced today the initiation of its IND-enabling pharmacology and toxicology non-human primate studies, under the direction of Yale School of Medicine Professor D. Eugene Redmond Jr. MD, the internationally recognized neurosurgeon and a leader in the use of stem cells for the treatment of Parkinson's disease. The studies will use non-human primates with moderate to severe Parkinson's disease symptoms to assess the safety and functional efficacy of ISCO's proprietary stem cell-derived neuronal cells. The endpoints of these multi-dose studies include determining cell fate, biodistribution and primate behavioral evaluations using a standardized rating scale to assess potential extrapyramidal side effects associated with the cell engraftment. The first, interim results are expected in Q4 of 2013 with the final results available in Q2 of 2014. Leading the studies will be Prof. Redmond, a recognized expert in the use of transplanted neural cells to treat parkinsonism in primates and the development of effective replacement strategies using stem cell derived neurons. In his career of over 25 years, Prof. Redmond has made many significant contributions in the field of cellular … Continue reading

Posted in Stem Cell Research | Comments Off on International Stem Cell Corporation Initiates IND-Enabling Study in Parkinson's Disease Program

Page 5,222«..1020..5,2215,2225,2235,224..5,2305,240..»